ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "depression"

  • Abstract Number: 43 • 2015 ACR/ARHP Annual Meeting

    Prevalence and Relevance of Depressive Symptoms in Patients with Rheumatic Diseases

    Stefan Kleinert1,2, Almuth Marx3, Hermann Faller4, Martin Feuchtenberger5, Christian Kneitz6, Stefanie Lehmann3, Hans Peter Tony7, Christiane Angermann3,8, Georg Ertl8, Stefan Störk3 and Margret Breunig3,9, 1Rheumatologische Schwerpunktpraxis Erlangen, Erlangen, Germany, 2University Hospital Würzburg, Würzburg, Germany, 3Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany, 4Abteilung für Medizinische Psychologie und Psychotherapie, University of Würzburg, Würzburg, Germany, 5Rheumatologie/Klinische Immunologie, Kreiskliniken Altötting-Burghausen, Burghausen, Germany, 6Internal Medicine II, Hospital Südstadt, Rostock, Germany, 7Rheumatology / Clinical Immunology, University Hospital Würzburg, Würzburg, Germany, 8Dept. of Internal Medicine / Cardiology, University Hospital Würzburg, Würzburg, Germany, 9Dept. of Internal Medicine / Cardiology, University Hospital Würzburg, Würzburg, Wuerzburg, Germany

    Background/Purpose: Patients with rheumatic diseases (RD) have an increased mortality risk compared to the normal population. The current prospective follow-up study investigated the prevalence of…
  • Abstract Number: 129 • 2015 ACR/ARHP Annual Meeting

    Rheumatologists’ Approaches to Diagnosis and Treatment of Depression

    Erica Heiman, Barton Wise and Richard L. Kravitz, Department of Internal Medicine, UC Davis Medical Center, Sacramento, CA

    Background/Purpose: Depression in patients with rheumatic disorders contributes to morbidity, mortality, and health care utilization. We set out to examine rheumatologists’ approaches to and perceptions…
  • Abstract Number: 335 • 2015 ACR/ARHP Annual Meeting

    Prevalence of Hand Osteoarthritis and Factors Associated with Pain in Korean Farmers

    Young Sun Suh1, Yun-Hong Cheon1, Hyun-Ok Kim1, Ki-Soo Park2, Hye Song Lim1, Min-Gyu Jeon1, Young-Sool Hah3 and Sang-Il Lee1, 1Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea, 2Department of Preventive Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea, 3Clinical Research Institute, Gyeongsang National University School of Medicine, Jinju, South Korea

    Background/Purpose: Farming activity is burdened work with excessive use of hands. Thus, farmers are expected to have high prevalence of hand osteoarthritis (HOA). However, there…
  • Abstract Number: 655 • 2015 ACR/ARHP Annual Meeting

    Rasch Analysis of the Hospital Anxiety and Depression Scale in Psoriatic Arthritis: Results from the Presta Study.  

    Mwidimi Ndosi1, Ming-Anne Hsu2, J. Cappelleri3, Heather Jones4, Amit Chhabra5 and Philip S. Helliwell6, 1School of Healthcare, University of Leeds, Leeds, United Kingdom, 2445 Eastern Point Road, Pfizer Inc, Groton, CT, 3Statistics, Pfizer Inc, New London, CT, 4Inflammation Global Medical Affairs, Pfizer, Collegeville, PA, 5Pfizer Inc, Collegeville, PA, 6Section of Musculoskeletal Disease, University of Leeds, Leeds, United Kingdom

    Background/Purpose: The Hospital Anxiety and Depression Scale (HADs) is a generic measure of psychological status comprising anxiety and depression subscales. The aim of this study…
  • Abstract Number: 2646 • 2014 ACR/ARHP Annual Meeting

    Mood Disorders in Systemic Lupus Erythematousus (SLE): Results from an International, Inception Cohort Study

    John G. Hanly for the Systemic Lupus International Collaborating Clinics1, Li Su2, Murray Urowitz3, Juanita Romero-Diaz4, Caroline Gordon5, Sang-Cheol Bae6, Sasha R Bernatsky7, Ann E. Clarke8, Daniel J. Wallace9, Joan T. Merrill10, David A. Isenberg11, Anisur Rahman12, Ellen M. Ginzler13, Paul Fortin14, Dafna D. Gladman15, Jorge Sanchez-Guerrero16, Michelle Petri17, Ian Bruce18, Mary Anne Dooley19, Rosalind Ramsey-Goldman20, Cynthia Aranow21, Graciela S. Alarcon22, Barri J. Fessler23, Kristján Steinsson24, Ola Nived25, Gunnar K. Sturfelt25, Susan Manzi26, Munther A. Khamashta27, Ronald F. van Vollenhoven28, Asad Zoma29, Manuel Ramos-Casals30, Guillermo Ruiz-Irastorza31, S. Sam Lim32, Thomas Stoll33, Murat Inanc34, Kenneth C. Kalunian35, Diane L. Kamen36, Peter Maddison37, Christine A. Peschken38, Søren Jacobsen39, Anca Askanase40, Jill P. Buyon41, Chris Theriault42, Kara Thompson42 and Vernon Farewell2, 1Division of Rheumatology, Dalhousie University and Capital Health, Nova Scotia, Canada, Halifax, NS, Canada, 2MRC Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge, United Kingdom, 3Medicine, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 4Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutricion, Mexico city, Mexico, 5Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, 6Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 7Division of Rheumatology and Clinical Epidemiology, McGill University, Montreal, Quebec, QC, Canada, 8Division of Rheumatology, University of Calgary, Alberta, Calgary, AB, Canada, 9Rheumatology, Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, 10Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 11Centre for Rheumatology Research, Rayne Building, 4th Floor, Centre for Rheumatology, Department of Medicine, University College London, London, United Kingdom, 12Centre for Rheumatology Research, University College London, London, United Kingdom, 13Rheumatology, SUNY-Downstate Medical Center, Brooklyn, NY, 14Medicine, Division of Rheumatology, Centre Hospitalier Universitaire de Quebec et Universite Laval, Quebec, QC, Canada, 15University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 16Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 17Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 18Kellgren Centre for Rheum, Arthritis Research UK Epidemiology Unit, Institution of Inflammation and Repair, University of Manchester, NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals, Manchester Academic Health Sciences Centre, Manchester, United Kingdom, 19Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, 20Rheumatology, Northwestern University and Feinberg School of Medicine, Chicago, IL, 21Feinstein Institute for Medical Research, Mahasset, NY, 22Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 23Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 24Centre for Rheumatology Research, Landspital University Hospital, Reykjavik, Iceland, 25Department of Rheumatology, University Hospital Lund, Lund, Sweden, 26Division of Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 27Lupus Research Unit, The Rayne Institute, St Thomas Hospital, Kings College London School of Medicine, London, United Kingdom, 28Unit for clinical therapy research (ClinTrid), Karolinska Institute, Stockholm, Sweden, 29Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, United Kingdom, 30Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain, 31Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain, 32Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, 33Kantonsspital Geissbergstr, Schaffhausen, Switzerland, 34Rheumatology, Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey, 35UCSD School of Medicine, La Jolla, CA, 36Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC, 37Ysbyty Gwynedd Bangor, North Wales, United Kingdom, 38University of Manitoba, Canada, Winnipeg, MB, Canada, 39Department of Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, 40Columbia University Medical Center, New York, NY, 41Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 42Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada

    Background/Purpose: Neuropsychiatric (NP) events in patients with SLE include mood disorders. We determined the frequency, characteristics, clinical and autoantibody associations of mood disorders in a…
  • Abstract Number: 2397 • 2014 ACR/ARHP Annual Meeting

    Improvement of Fatigue in Patients with Rheumatoid Arthritis Treated with  Biologics: Relationship with Sleep Disorders, Depression and Clinical Efficacy. a Prospective, Multicenter Study

    Marlène Genty1, Marie Kostine2, Elodie Ardouin3, Bernard Combe4 and Cédric Lukas5, 1RHEUMATOLOGY, CHU LAPEYRONIE, MONTPELLIER, France, 2Rheumatology, CHU Pellegrin, Bordeaux, France, 3Rheumatology, Limoges University Hospital, Limoges, France, 4Immuno-Rhumatologie, Hôpital Lapeyronie, Montpellier, France, 5Immuno-Rhumatologie, Hopital Lapeyronie, Montpellier, France

    Background/Purpose The functional burden of disease in Rheumatoid arthritis (RA) patients, mainly caused by inflamed joints, is often worsened by extra-articular manifestations, among which asthenia remains…
  • Abstract Number: 2056 • 2014 ACR/ARHP Annual Meeting

    Fibromyalgia Symptoms Beyond the Pain and Its Impact on the Patient

    Abdelmoneim Helal1, Dia MF Mohasseb2, Noha AH El-Sawy2 and Yousra H. Abdel-Fattah3, 1Physical Medicine, Rheumatology & rehabilitation, Professor, Alexandria, Egypt, 2Physical Medicine, Rheumatology and Rehabilitation, Professor, Alexandria, Egypt, 3Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, University of Alexandria, Alexandria, Egypt

    Background/Purpose: Fibromyalgia (FM) has been promoted as the commonest cause of chronic, widespread non-articular musculoskeletal pain, stiffness and fatigue. Although pain is the central feature…
  • Abstract Number: 1811 • 2014 ACR/ARHP Annual Meeting

    The Burden of Depression on Healthcare Utilization in a Population-Based Cohort of Patients with Systemic Lupus Erythematosus

    Alfredo Aguirre1, Gaobin Bao2, S. Sam Lim3 and Cristina Drenkard4, 1Department of Rheumatology, Emory University, Atlanta, GA, 2Medicine, Emory University, Atlanta, GA, 3Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, 4Medicine, Div Rheumatology, Emory University, Atlanta, GA

    Background/Purpose . Systemic lupus erythematosus (SLE) is a chronic disease that disproportionately strikes black women. Depression is a potentially debilitating co-morbidity that affects 15-75% of…
  • Abstract Number: 1558 • 2014 ACR/ARHP Annual Meeting

    Evaluation of Extreme Enthesitis and/or Patient-Related Outcome Score As Potential Surrogates for Fibromyalgia and As Potential Confounding Factors of Anti-TNF Response

    M Dougados1, H Jones2, A Szumski3, I Logeart4 and J Coindreau5, 1Université Paris René Descartes and Hôpital Cochin, Paris, France, 2Inflammation & Immunology, Pfizer Inc., Collegeville, PA, 3Pfizer Inc., Collegeville, PA, 4Pfizer, Paris, France, 5Pfizer Inc., New York, NY

    Background/Purpose: Differentiating between pain related to spondyloarthritis (in particular polyenthesitis) and pain related to fibromyalgia can be challenging, both in daily practice and in clinical…
  • Abstract Number: 1436 • 2014 ACR/ARHP Annual Meeting

    Impact of Depression on Clinical and Social Outcomes in Patients with Rheumatoid Arthritis: Comparative Study in Germany and Brazil

    Harriet Morf1, Olga Malysheva2, G da Rocha3, Anna Beatriz Vargas3 and Christoph G. Baerwald2, 1Department of Internal Medicine, University Hospital, Leipzig, Germany, 2Rheumatology, University Hospital, Leipzig, Germany, 3Ambulatório de reumatologia da Policlínica Piquet Carneiro, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

    Background/Purpose Rheumatoid Arthritis (RA) can be associated with psychological disorders and especially depression. About 13 – 20 % of patients have clinical significant depression. It…
  • Abstract Number: 1363 • 2014 ACR/ARHP Annual Meeting

    Psychosocial Comorbidities Are Independently Associated with Subclinical Atherosclerosis in Rheumatoid Arthritis

    Ying Liu1, Moyses Szklo2, Karina Davidson3, Joan Bathon4 and Jon Giles3, 1Internal Medicine, Columbia University Medical Center, New York, NY, 2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 3Columbia University Medical Center, New York, NY, 4Medicine, Columbia University, New York, NY

    Background/Purpose: Rheumatoid arthritis (RA) is associated with higher rates of cardiovascular disease (CVD) and subclinical atherosclerosis as well as psychosocial comorbidities, which themselves are associated…
  • Abstract Number: 1339 • 2014 ACR/ARHP Annual Meeting

    Is Psychological Status Related to Symptom Experience in Behçet’s Syndrome?

    Robert Moots1 and Sophie Campbell2, 1Musculoskeletal Biology, University of Liverpool, Liverpool, United Kingdom, 2Behcets Centre, Aintree University Hospital, Liverpool, United Kingdom

    Background/Purpose Little is known about the impact of Behçet’s Syndrome (BS) within the UK.  The recent establishment of National Centres of Excellence now allows a…
  • Abstract Number: 1116 • 2014 ACR/ARHP Annual Meeting

    Mindfulness Is Associated with Sleep Quality Among Patients with Fibromyalgia

    Yuan Zhang1, Lori Lyn Price2, Nani Morgan3, Lucas Morgan4 and Chenchen Wang5, 1School of Nursing, University of Massachusetts Lowell, Lowell, MA, 2Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 3Internal Medicine Residency Program, University of Hawaii, Honolulu, HI, 4Clinical Psychology, University of Massachusetts, Honolulu, HI, 5Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose: Mindfulness is the ability to observe, describe, or be aware of present moment experiences without judgment or reactivity. Previous literature suggests that mindfulness-based interventions…
  • Abstract Number: 1108 • 2014 ACR/ARHP Annual Meeting

    Understanding Baseline Clinical Characteristics May be of Use in Considering the Response to Pregabalin in FM Patients with Comorbid Depression

    Lynne Pauer1, Jaren Landen2, Pritha Bhadra Brown3, Joseph Scavone2, Richard Vissing4 and Andrew Clair3, 1445 Eastern Point Road, Pfizer Inc, Groton, CT, 2Pfizer Inc, Groton, CT, 3Pfizer Inc, New York, NY, 4Pfizer Inc, Louisville, KY

    Background/Purpose In a prior study in fibromyalgia (FM) patients taking an antidepressant for their comorbid depression, pregabalin (PGB) significantly reduced pain severity (treatment difference compared…
  • Abstract Number: 1084 • 2014 ACR/ARHP Annual Meeting

    Obesity Is a Risk Factor for Depression in Systemic Lupus Erythematosus (SLE)

    Patricia P. Katz1, Stephanie Rush2, Laura Trupin3, Jennifer Barton3, Gabriela Schmajuk3, Jinoos Yazdany3, Chris Tonner4 and Mary Margaretten3, 1Medicine, University of California, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA, 3Medicine, University of California, San Francisco, San Francisco, CA, 43333 California Street, Box 09, University of California, San Francisco, San Francisco, CA

    Background/Purpose: General population studies have found significant relationships between obesity and depression, including identifying obesity as a risk factor for onset of depression.  In SLE,…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology